Ala-ala-asn-pab peptide linkers improve physiochemical property and toxicity profiles of cytotoxic drugs by forming a peptide-drug conjugate. The peptide drug conjugate can be cleaved by cellular proteases and release the cytotoxic drugs in their active form.
AxisPharm developed a novel process to synthesize ala-ala-asn-pab and its derivatives in large scale. For custom synthesis please contact us.
